{"title":"Drug Development ELISA Kits","description":null,"products":[{"product_id":"human-ada-adenosine-deaminase-elisa-kit-picokine-bhe21001058","title":"Human ADA\/Adenosine Deaminase ELISA Kit PicoKine®","description":"\u003cstyle\u003e\n.bhp-desc{font-size:16px;color:#1a1a1a;line-height:1.7}\n.bhp-desc h2{font-size:18px;font-weight:700;color:#003366;margin:24px 0 10px;padding-bottom:6px;border-bottom:2px solid #003366}\n.bhp-desc p{margin:0 0 12px}\n.bhp-desc .bhp-spec-table{width:100%;border-collapse:collapse;margin:12px 0 18px}\n.bhp-desc .bhp-spec-table th{width:36%;text-align:left;padding:8px 12px;background:#e8f0fb;color:#003366;font-weight:600;vertical-align:top;border:1px solid #ccd9f0}\n.bhp-desc .bhp-spec-table td{padding:8px 12px;vertical-align:top;border:1px solid #ccd9f0}\n.bhp-desc .bhp-warning-box{background:#fff8e6;border-left:4px solid #e6a817;padding:10px 14px;margin:10px 0 14px;border-radius:0 4px 4px 0}\n.bhp-desc .bhp-cat-pill{display:inline-block;background:#003366;color:#fff;border-radius:20px;padding:3px 12px;font-size:13px;margin-bottom:10px}\n\u003c\/style\u003e\n\u003cdiv class=\"bhp-desc\"\u003e\n\u003cspan class=\"bhp-cat-pill\"\u003eSandwich ELISA · PicoKine®\u003c\/span\u003e\n\u003ch2\u003eAssay Principle\u003c\/h2\u003e\n\u003cp\u003eThis sandwich ELISA quantifies human \u003cstrong\u003eadenosine deaminase\u003c\/strong\u003e (gene \u003cem\u003eADA\u003c\/em\u003e) in cell culture supernatants, serum and pleural fluid. Strips are pre-coated with a capture antibody. After the sample is added, a biotinylated detection antibody binds the captured protein, and an avidin–biotin–peroxidase complex supplies the enzyme. TMB develops color in proportion to the bound target; the reaction is stopped and read at 450 nm, and concentrations are read from the standard curve.\u003c\/p\u003e\n\u003cp\u003eAdenosine deaminase (ADA) converts adenosine and deoxyadenosine to inosine and deoxyinosine, controlling adenosine levels inside and outside cells. It is essential for lymphocyte development, and ADA deficiency causes a form of severe combined immunodeficiency (SCID).\u003c\/p\u003e\n\u003ch2\u003eKit Components\u003c\/h2\u003e\n\u003ctable class=\"bhp-spec-table\"\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003eAnti-Human ADA Pre-coated 96-well strip microplate\u003c\/th\u003e\n\u003ctd\u003e1 plate (96 wells)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eHuman ADA Standard\u003c\/th\u003e\n\u003ctd\u003e2 vials, 10 ng\/tube\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eHuman ADA Biotinylated antibody (100x)\u003c\/th\u003e\n\u003ctd\u003e100 µL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eAvidin-Biotin-Peroxidase Complex (100x)\u003c\/th\u003e\n\u003ctd\u003e100 µL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample Diluent\u003c\/th\u003e\n\u003ctd\u003e30 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eAntibody Diluent\u003c\/th\u003e\n\u003ctd\u003e12 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eAvidin-Biotin-Peroxidase Diluent\u003c\/th\u003e\n\u003ctd\u003e12 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eColor Developing Reagent (TMB)\u003c\/th\u003e\n\u003ctd\u003e10 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStop Solution\u003c\/th\u003e\n\u003ctd\u003e10 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eWash Buffer (25x)\u003c\/th\u003e\n\u003ctd\u003e20 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eAdhesive plate sealers\u003c\/th\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eAlso required (not supplied):\u003c\/strong\u003e microplate reader for 450 nm; incubator; automated plate washer (optional); precision pipettes for 0.5 µL through 1 mL volumes of aqueous solutions; multichannel pipettes (recommended for many samples); deionized or distilled water; 500 mL graduated cylinders; test tubes for dilution.\u003c\/p\u003e\n\u003cp\u003eKit components are not sold separately.\u003c\/p\u003e\n\u003ch2\u003ePerformance Data\u003c\/h2\u003e\n\u003ctable class=\"bhp-spec-table\"\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003eSpecies\u003c\/th\u003e\n\u003ctd\u003eHuman\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample types\u003c\/th\u003e\n\u003ctd\u003eCell culture supernatants, serum and pleural fluid\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eAssay range\u003c\/th\u003e\n\u003ctd\u003e31.2 pg\/mL–2,000 pg\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSensitivity\u003c\/th\u003e\n\u003ctd\u003e\u0026lt;10 pg\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStandard\u003c\/th\u003e\n\u003ctd\u003eRecombinant human ADA (Ala2–Leu363), expressed in NS0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eCross-reactivity\u003c\/th\u003e\n\u003ctd\u003eNone detected against related proteins in supplier testing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eIntra-assay CV\u003c\/th\u003e\n\u003ctd\u003e4.0–6.1% (3 samples, n = 16 each)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eInter-assay CV\u003c\/th\u003e\n\u003ctd\u003e4.8–7.3% (3 samples, n = 24 each)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFormat\u003c\/th\u003e\n\u003ctd\u003e96 wells, removable strips\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eSample dilution:\u003c\/strong\u003e start at 1:1. In the supplier’s tests, serum samples measured about 400 pg\/mL.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eExample standard curve (OD\u003csub\u003e450\u003c\/sub\u003e, pg\/mL):\u003c\/strong\u003e 0 = 0.035; 31.2 = 0.0825; 62.5 = 0.1318; 125 = 0.2298; 250 = 0.3985; 500 = 0.72; 1000 = 1.278; 2000 = 2.043. Run a new standard curve on every plate.\u003c\/p\u003e\n\u003ch2\u003eStorage \u0026amp; Handling\u003c\/h2\u003e\n\u003cp\u003eStore at 4 °C for up to 6 months or −20 °C for up to 12 months. Avoid repeated freeze–thaw cycles. Ships on gel ice and tolerates up to 3 days at room temperature; freeze on arrival.\u003c\/p\u003e\n\u003ch2\u003eSafety\u003c\/h2\u003e\n\u003cdiv class=\"bhp-warning-box\"\u003eThe stop solution and substrate are chemical reagents; wear gloves and eye protection and follow the SDS. Treat serum, plasma and other biological samples as potentially infectious. For research use only; not for diagnostic procedures.\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Boster Bio","offers":[{"title":"96 wells\/kit, with removable strips.","offer_id":52920845500781,"sku":"EK1446","price":513.97,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/ek1446_86ed42c8-4af6-4ded-9123-c251679e7df5.png?v=1769078012"},{"product_id":"adalimumab-humira-pharmacokinetic-elisa-bhe18300001","title":"Adalimumab (Humira) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAdalimumab (Humira) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Adalimumab (Humira) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Adalimumab (Humira) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Adalimumab (Humira) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693544301,"sku":"EL-1611-011-96WELLSX1","price":885.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3.jpg?v=1769074193"},{"product_id":"bevacizumab-avastin-pharmacokinetic-elisa-bhe18300002","title":"Bevacizumab (Avastin) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eBevacizumab (Avastin) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Bevacizumab (Avastin) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Bevacizumab (Avastin) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Bevacizumab (Avastin) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693577069,"sku":"EL-1611-021-96WELLSX1","price":885.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_72adf560-2dda-44be-a977-e069e492b0b4.jpg?v=1769074193"},{"product_id":"cetuximab-erbitux-pharmacokinetic-elisa-bhe18300003","title":"Cetuximab (Erbitux) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eCetuximab (Erbitux) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Cetuximab (Erbitux) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Cetuximab (Erbitux) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Cetuximab (Erbitux) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693609837,"sku":"EL-1611-031-96WELLSX1","price":885.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_c87b9703-3d3b-4aa3-aec2-5757c628bf2b.jpg?v=1769074193"},{"product_id":"etanercept-enbrel-pharmacokinetic-elisa-bhe18300004","title":"Etanercept (Enbrel) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eEtanercept (Enbrel) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Etanercept (Enbrel) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Etanercept (Enbrel) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Etanercept (Enbrel) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693642605,"sku":"EL-1611-051-96WELLSX1","price":885.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_90308f58-4509-4410-ad2f-9d3e9042efdd.jpg?v=1769074193"},{"product_id":"infliximab-remicade-pharmacokinetic-elisa-bhe18300005","title":"Infliximab (Remicade) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eInfliximab (Remicade) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Infliximab (Remicade) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Infliximab (Remicade) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Infliximab (Remicade) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693675373,"sku":"EL-1611-091-96WELLSX1","price":885.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_1e3c2d85-2ff6-4956-bd07-a287764fe75c.jpg?v=1769074194"},{"product_id":"natalizumab-tysabri-pharmacokinetic-elisa-bhe18300006","title":"Natalizumab (Tysabri) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eNatalizumab (Tysabri) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Natalizumab (Tysabri) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Natalizumab (Tysabri) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Natalizumab (Tysabri) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693708141,"sku":"EL-1611-141-96WELLSX1","price":885.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_0bfb53bf-c4b5-492a-b4fc-42d7766e9096.jpg?v=1769074194"},{"product_id":"omalizumab-xolair-pharmacokinetic-elisa-bhe18300007","title":"Omalizumab (Xolair) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eOmalizumab (Xolair) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Omalizumab (Xolair) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Omalizumab (Xolair) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Omalizumab (Xolair) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693740909,"sku":"EL-1611-152-96WELLSX1","price":885.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_7627450f-efda-4751-9c58-c02a305d3739.jpg?v=1769074194"},{"product_id":"rituximab-rituxan-pharmacokinetic-elisa-bhe18300008","title":"Rituximab (Rituxan) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eRituximab (Rituxan) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Rituximab (Rituxan) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Rituximab (Rituxan) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Rituximab (Rituxan) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693773677,"sku":"EL-1611-181-96WELLSX1","price":885.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_4441adfe-54f5-47ae-8d3c-54d337cbe2ab.jpg?v=1769074195"},{"product_id":"trastuzumab-herceptin-pharmacokinetic-elisa-bhe18300009","title":"Trastuzumab (Herceptin) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eTrastuzumab (Herceptin) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Trastuzumab (Herceptin) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Trastuzumab (Herceptin) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Trastuzumab (Herceptin) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693806445,"sku":"EL-1611-201-96WELLSX1","price":885.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_64fccc38-df7a-4964-8491-1be9c359fbb1.jpg?v=1769074195"},{"product_id":"tocilizumab-actemra-pharmacokinetic-elisa-bhe18300010","title":"Tocilizumab (Actemra) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eTocilizumab (Actemra) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Tocilizumab (Actemra) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Tocilizumab (Actemra) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Tocilizumab (Actemra) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693839213,"sku":"EL-1611-202-96WELLSX1","price":885.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_930d673a-3aa8-4135-a952-760e6b41c248.jpg?v=1769074195"},{"product_id":"rituximab-rituxan-immunogenicity-elisa-bhe18300011","title":"Rituximab (Rituxan) Immunogenicity ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eRituximab (Rituxan) Immunogenicity\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Rituximab (Rituxan) Immunogenicity in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Rituximab (Rituxan) Immunogenicity may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Rituximab (Rituxan) Immunogenicity participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693871981,"sku":"EL-141-181-96WELLSX1","price":885.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_e82218ea-48f0-464f-8227-a01d014d87bc.jpg?v=1769074196"},{"product_id":"trastuzumab-herceptin-immunogenicity-elisa-bhe18300012","title":"Trastuzumab (Herceptin) Immunogenicity ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eTrastuzumab (Herceptin) Immunogenicity\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Trastuzumab (Herceptin) Immunogenicity in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Trastuzumab (Herceptin) Immunogenicity may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Trastuzumab (Herceptin) Immunogenicity participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693904749,"sku":"EL-141-201-96WELLSX1","price":885.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_0f51ce42-2b3b-4f37-9884-8c03c5923d8b.jpg?v=1769074196"},{"product_id":"human-growth-hormone-hgh-somatropin-pharmacokinetic-elisa-bhe18300018","title":"Human growth hormone (hGH) (Somatropin) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eHuman growth hormone (hGH) (Somatropin) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. Hormones and peptide mediators support systemic communication across organs and physiological states.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Human growth hormone (hGH) (Somatropin) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Human growth hormone (hGH) (Somatropin) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Human growth hormone (hGH) (Somatropin) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950694134125,"sku":"EL-1611-878-96WELLSX1","price":885.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_189dfff3-2037-4fa6-9ed1-78ba9e95be7b.jpg?v=1769074198"},{"product_id":"filgrastim-gcsf-pharmacokinetic-elisa-el-1611-73196-bhe18300019","title":"Filgrastim (GCSF) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eFilgrastim (GCSF) Pharmacokinetic ELISA | EL-1611-73196\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Filgrastim (GCSF) Pharmacokinetic ELISA | EL-1611-73196 in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Filgrastim (GCSF) Pharmacokinetic ELISA | EL-1611-73196 may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Filgrastim (GCSF) Pharmacokinetic ELISA | EL-1611-73196 participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950694199661,"sku":"EL-1611-73196-96WELLSX1","price":885.79,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_72e24776-0681-4569-a6fa-73700985af70.jpg?v=1769074198"},{"product_id":"human-adenosine-deaminase-ada-elisa-kit-bhe12102456","title":"Human Adenosine Deaminase, ADA ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAdenosine Deaminase (ADA)\u003c\/strong\u003e is a molecular target commonly studied in epigenetics and nuclear signaling research. This molecule is commonly investigated as part of broader signaling, regulatory, or homeostatic networks.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eUniProt\u003c\/strong\u003e: P00813\u003c\/p\u003e\u003ch2\u003eBiological role and pathway context\u003c\/h2\u003e\u003cp\u003eIn the literature, Adenosine Deaminase (ADA) is frequently examined in relation to mechanistic biology studies, biomarker-focused profiling, and disease-model research. Depending on the model system, changes in abundance can be associated with shifts in signaling state, cellular composition, or tissue physiology.\u003c\/p\u003e\u003ch2\u003eExpression and regulation\u003c\/h2\u003e\u003cp\u003eExpression of Adenosine Deaminase (ADA) can vary across tissues and cell types and may change under conditions such as immune activation, stress responses, injury, infection, or metabolic perturbation. Reported regulation may involve transcriptional control as well as post-translational processes that influence stability, localization, processing, or secretion.\u003c\/p\u003e\u003ch2\u003eResearch and disease relevance\u003c\/h2\u003e\u003cp\u003eAdenosine Deaminase (ADA) has been reported as a useful readout in studies of physiological regulation and disease-associated processes. These observations make it relevant for hypothesis-driven research and biomarker exploration, while interpretation should remain grounded in the specific species, sample matrix, and study design.\u003c\/p\u003e\u003ch2\u003eInterpreting concentration measurements\u003c\/h2\u003e\u003cp\u003eMeasured levels of Adenosine Deaminase (ADA) can reflect multiple biological factors, including production rate, turnover, compartmental distribution, and sample composition. As a result, conclusions are often supported by considering broader pathway context and complementary readouts rather than relying on a single analyte alone.\u003c\/p\u003e\u003ch2\u003eNomenclature\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAdenosine Deaminase (ADA)\u003c\/strong\u003e may also be referred to as \u003cstrong\u003eADA\u003c\/strong\u003e, \u003cstrong\u003eAdenosine aminohydrolase\u003c\/strong\u003e, and \u003cstrong\u003eAdenosine deaminase\u003c\/strong\u003e in publications and databases. Nomenclature differences and species context can influence how results are compared across studies.\u003c\/p\u003e","brand":"Bioassay Technology Laboratory","offers":[{"title":"96T","offer_id":52952462262637,"sku":"E0777Hu-96T","price":458.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/E0777Hu.jpg?v=1769146080"},{"product_id":"mouse-adenosine-deaminase-ada-elisa-kit-bhe12109442","title":"Mouse Adenosine Deaminase, ADA ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAdenosine Deaminase (ADA)\u003c\/strong\u003e is a molecular target commonly studied in epigenetics and nuclear signaling research. This molecule is commonly investigated as part of broader signaling, regulatory, or homeostatic networks.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eUniProt\u003c\/strong\u003e: P03958\u003c\/p\u003e\u003ch2\u003eBiological role and pathway context\u003c\/h2\u003e\u003cp\u003eIn the literature, Adenosine Deaminase (ADA) is frequently examined in relation to mechanistic biology studies, biomarker-focused profiling, and disease-model research. Depending on the model system, changes in abundance can be associated with shifts in signaling state, cellular composition, or tissue physiology.\u003c\/p\u003e\u003ch2\u003eExpression and regulation\u003c\/h2\u003e\u003cp\u003eExpression of Adenosine Deaminase (ADA) can vary across tissues and cell types and may change under conditions such as immune activation, stress responses, injury, infection, or metabolic perturbation. Reported regulation may involve transcriptional control as well as post-translational processes that influence stability, localization, processing, or secretion.\u003c\/p\u003e\u003ch2\u003eResearch and disease relevance\u003c\/h2\u003e\u003cp\u003eAdenosine Deaminase (ADA) has been reported as a useful readout in studies of physiological regulation and disease-associated processes. These observations make it relevant for hypothesis-driven research and biomarker exploration, while interpretation should remain grounded in the specific species, sample matrix, and study design.\u003c\/p\u003e\u003ch2\u003eInterpreting concentration measurements\u003c\/h2\u003e\u003cp\u003eMeasured levels of Adenosine Deaminase (ADA) can reflect multiple biological factors, including production rate, turnover, compartmental distribution, and sample composition. As a result, conclusions are often supported by considering broader pathway context and complementary readouts rather than relying on a single analyte alone.\u003c\/p\u003e\u003ch2\u003eNomenclature\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAdenosine Deaminase (ADA)\u003c\/strong\u003e may also be referred to as \u003cstrong\u003eADA\u003c\/strong\u003e, \u003cstrong\u003eAdenosine aminohydrolase\u003c\/strong\u003e, and \u003cstrong\u003eAdenosine deaminase\u003c\/strong\u003e in publications and databases. Nomenclature differences and species context can influence how results are compared across studies.\u003c\/p\u003e","brand":"Bioassay Technology Laboratory","offers":[{"title":"96T","offer_id":52952626725229,"sku":"E1600Mo-96T","price":458.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/E1600Mo.jpg?v=1769147093"},{"product_id":"rat-ada-adenosine-deaminase-elisa-kit-bhe152011205","title":"Rat ADA(Adenosine Deaminase) ELISA Kit","description":"\u003ch3\u003eScientific background\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).\u003c\/p\u003e\u003cp\u003eProtein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.\u003c\/p\u003e\u003cp\u003eQuantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.\u003c\/p\u003e\u003ch3\u003eWhy it matters\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuantify \u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e to compare biological changes across conditions, doses, or time points.\u003c\/li\u003e\n\u003cli\u003eGenerate concentration data from a standard curve to support biomarker and mechanistic studies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow the ELISA works\u003c\/h3\u003e\u003cp\u003eDesigned for \u003cstrong\u003eRat\u003c\/strong\u003e samples, this kit uses a \u003cstrong\u003eThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Rat ADA. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Rat ADA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Rat ADA, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Rat ADA in the samples is then determined by comparing the OD of the samples to the standard curve.\u003c\/strong\u003e. After binding and washing, signal is converted to concentration using a standard curve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample types\u003c\/strong\u003e: Serum, plasma, tissue homogenates and other biological fluids.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetection range\u003c\/strong\u003e: 0.16-10 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensitivity\/LoD\u003c\/strong\u003e: 0.071 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAssay time\u003c\/strong\u003e: 3.5h\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELK Biotechnology","offers":[{"title":"96 T","offer_id":52964646912365,"sku":"ELK9467-96T","price":595.4,"currency_code":"USD","in_stock":true},{"title":"48 T","offer_id":52964646945133,"sku":"ELK9467-48T","price":416.0,"currency_code":"USD","in_stock":true},{"title":"96 T X 5","offer_id":52964646977901,"sku":"ELK9467-96TX5","price":2531.1,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/1h1qbq4v21p4717oo1b_daf9c04c-4278-4452-8b74-cc93e6d0e6a5.jpg?v=1771841199"},{"product_id":"horse-ada-adenosine-deaminase-elisa-kit-bhe152011565","title":"Horse ADA(Adenosine Deaminase) ELISA Kit","description":"\u003ch3\u003eScientific background\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).\u003c\/p\u003e\u003cp\u003eProtein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.\u003c\/p\u003e\u003cp\u003eQuantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.\u003c\/p\u003e\u003ch3\u003eWhy it matters\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuantify \u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e to compare biological changes across conditions, doses, or time points.\u003c\/li\u003e\n\u003cli\u003eGenerate concentration data from a standard curve to support biomarker and mechanistic studies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow the ELISA works\u003c\/h3\u003e\u003cp\u003eDesigned for \u003cstrong\u003eHorse\u003c\/strong\u003e samples, this kit uses a \u003cstrong\u003eThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Horse ADA. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Horse ADA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Horse ADA, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Horse ADA in the samples is then determined by comparing the OD of the samples to the standard curve.\u003c\/strong\u003e. After binding and washing, signal is converted to concentration using a standard curve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample types\u003c\/strong\u003e: Serum, plasma, tissue homogenates and other biological fluids.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetection range\u003c\/strong\u003e: 0.16-10 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensitivity\/LoD\u003c\/strong\u003e: 0.068 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAssay time\u003c\/strong\u003e: 3.5h\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELK Biotechnology","offers":[{"title":"96 T","offer_id":52964686528877,"sku":"ELK9823-96T","price":595.4,"currency_code":"USD","in_stock":true},{"title":"48 T","offer_id":52964686561645,"sku":"ELK9823-48T","price":416.0,"currency_code":"USD","in_stock":true},{"title":"96 T X 5","offer_id":52964686594413,"sku":"ELK9823-96TX5","price":2531.1,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/1h1qbq4v21p4717oo1b_200954ff-7fd6-46f2-9522-4d0f1bcc6dfd.jpg?v=1771841445"},{"product_id":"human-adalimumab-elisa-kit-bhe152011568","title":"Human Adalimumab ELISA Kit","description":"\u003ch3\u003eScientific background\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAdalimumab\u003c\/strong\u003e is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).\u003c\/p\u003e\u003cp\u003eProtein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.\u003c\/p\u003e\u003cp\u003eQuantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.\u003c\/p\u003e\u003ch3\u003eWhy it matters\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuantify \u003cstrong\u003eAdalimumab\u003c\/strong\u003e to compare biological changes across conditions, doses, or time points.\u003c\/li\u003e\n\u003cli\u003eGenerate concentration data from a standard curve to support biomarker and mechanistic studies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow the ELISA works\u003c\/h3\u003e\u003cp\u003eDesigned for \u003cstrong\u003eHuman\u003c\/strong\u003e samples, this kit uses a \u003cstrong\u003eThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human Adalimumab. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human Adalimumab. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human Adalimumab, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Adalimumab in the samples is then determined by comparing the OD of the samples to the standard curve.\u003c\/strong\u003e. After binding and washing, signal is converted to concentration using a standard curve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample types\u003c\/strong\u003e: serum, plasma.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetection range\u003c\/strong\u003e: 15.63-1000 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensitivity\/LoD\u003c\/strong\u003e: 4.93 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAssay time\u003c\/strong\u003e: 3.5h\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELK Biotechnology","offers":[{"title":"96 T","offer_id":52964686889325,"sku":"ELK9826-96T","price":595.4,"currency_code":"USD","in_stock":true},{"title":"48 T","offer_id":52964686922093,"sku":"ELK9826-48T","price":416.0,"currency_code":"USD","in_stock":true},{"title":"96 T X 5","offer_id":52964686954861,"sku":"ELK9826-96TX5","price":2531.1,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/1h1qbq4v21p4717oo1b_bfc9585d-9cf1-4f0e-8e0c-60d4d606c49c.jpg?v=1771841448"},{"product_id":"human-ada-adenosine-deaminase-elisa-kit-bhe15203756","title":"Human ADA(Adenosine Deaminase) ELISA Kit","description":"\u003ch3\u003eScientific background\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).\u003c\/p\u003e\u003cp\u003eProtein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.\u003c\/p\u003e\u003cp\u003eQuantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.\u003c\/p\u003e\u003ch3\u003eWhy it matters\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuantify \u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e to compare biological changes across conditions, doses, or time points.\u003c\/li\u003e\n\u003cli\u003eGenerate concentration data from a standard curve to support biomarker and mechanistic studies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow the ELISA works\u003c\/h3\u003e\u003cp\u003eDesigned for \u003cstrong\u003eHuman\u003c\/strong\u003e samples, this kit uses a \u003cstrong\u003eThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human ADA. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human ADA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human ADA, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human ADA in the samples is then determined by comparing the OD of the samples to the standard curve.\u003c\/strong\u003e. After binding and washing, signal is converted to concentration using a standard curve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample types\u003c\/strong\u003e: Serum, plasma, tissue homogenates and other biological fluids.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetection range\u003c\/strong\u003e: 0.16-10 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensitivity\/LoD\u003c\/strong\u003e: 0.066 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAssay time\u003c\/strong\u003e: 3.5h\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELK Biotechnology","offers":[{"title":"96 T","offer_id":52965379604845,"sku":"ELK1970-96T","price":595.4,"currency_code":"USD","in_stock":true},{"title":"48 T","offer_id":52965379637613,"sku":"ELK1970-48T","price":416.0,"currency_code":"USD","in_stock":true},{"title":"96 T X 5","offer_id":52965379670381,"sku":"ELK1970-96TX5","price":2531.1,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/1h1qbq4v21p4717oo1b_e7f8e256-4bc8-47ca-9b37-886f3a517330.jpg?v=1771843110"},{"product_id":"chicken-ada-adenosine-deaminase-elisa-kit-bhe15207908","title":"Chicken ADA(Adenosine Deaminase) ELISA Kit","description":"\u003ch3\u003eScientific background\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).\u003c\/p\u003e\u003cp\u003eProtein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.\u003c\/p\u003e\u003cp\u003eQuantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.\u003c\/p\u003e\u003ch3\u003eWhy it matters\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuantify \u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e to compare biological changes across conditions, doses, or time points.\u003c\/li\u003e\n\u003cli\u003eGenerate concentration data from a standard curve to support biomarker and mechanistic studies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow the ELISA works\u003c\/h3\u003e\u003cp\u003eDesigned for \u003cstrong\u003eChicken\u003c\/strong\u003e samples, this kit uses a \u003cstrong\u003eThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Chicken ADA. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Chicken ADA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Chicken ADA, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Chicken ADA in the samples is then determined by comparing the OD of the samples to the standard curve.\u003c\/strong\u003e. After binding and washing, signal is converted to concentration using a standard curve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample types\u003c\/strong\u003e: Serum, plasma, tissue homogenates and other biological fluids.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetection range\u003c\/strong\u003e: 0.16-10 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensitivity\/LoD\u003c\/strong\u003e: 0.067 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAssay time\u003c\/strong\u003e: 3.5h\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELK Biotechnology","offers":[{"title":"96 T","offer_id":52965907628397,"sku":"ELK8740-96T","price":595.4,"currency_code":"USD","in_stock":true},{"title":"48 T","offer_id":52965907661165,"sku":"ELK8740-48T","price":416.0,"currency_code":"USD","in_stock":true},{"title":"96 T X 5","offer_id":52965907693933,"sku":"ELK8740-96TX5","price":2531.1,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/1h1qbq4v21p4717oo1b_6d175d3d-2e81-4f59-90ef-605237e1db27.jpg?v=1771845287"},{"product_id":"human-infliximab-elisa-kit-bhe15208509","title":"Human Infliximab ELISA Kit","description":"\u003ch3\u003eScientific background\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eInfliximab\u003c\/strong\u003e is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).\u003c\/p\u003e\u003cp\u003eProtein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.\u003c\/p\u003e\u003cp\u003eQuantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.\u003c\/p\u003e\u003ch3\u003eWhy it matters\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuantify \u003cstrong\u003eInfliximab\u003c\/strong\u003e to compare biological changes across conditions, doses, or time points.\u003c\/li\u003e\n\u003cli\u003eGenerate concentration data from a standard curve to support biomarker and mechanistic studies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow the ELISA works\u003c\/h3\u003e\u003cp\u003eDesigned for \u003cstrong\u003eHuman\u003c\/strong\u003e samples, this kit uses a \u003cstrong\u003eThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human Infliximab. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human Infliximab. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human Infliximab, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Infliximab in the samples is then determined by comparing the OD of the samples to the standard curve.\u003c\/strong\u003e. After binding and washing, signal is converted to concentration using a standard curve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample types\u003c\/strong\u003e: Serum, plasma, tissue homogenates and other biological fluids.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetection range\u003c\/strong\u003e: 4.69-300 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensitivity\/LoD\u003c\/strong\u003e: 1.77 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAssay time\u003c\/strong\u003e: 3.5h\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELK Biotechnology","offers":[{"title":"96 T","offer_id":52965967921517,"sku":"ELK0764-96T","price":595.4,"currency_code":"USD","in_stock":true},{"title":"48 T","offer_id":52965967954285,"sku":"ELK0764-48T","price":416.0,"currency_code":"USD","in_stock":true},{"title":"96 T X 5","offer_id":52965967987053,"sku":"ELK0764-96TX5","price":2531.1,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/1h1qbq4v21p4717oo1b_8c2fc0ea-d285-4061-aaae-927412f45f7e.jpg?v=1771845602"},{"product_id":"mouse-ada-adenosine-deaminase-elisa-kit-bhe15210421","title":"Mouse ADA(Adenosine Deaminase) ELISA Kit","description":"\u003ch3\u003eScientific background\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).\u003c\/p\u003e\u003cp\u003eProtein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.\u003c\/p\u003e\u003cp\u003eQuantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.\u003c\/p\u003e\u003ch3\u003eWhy it matters\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuantify \u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e to compare biological changes across conditions, doses, or time points.\u003c\/li\u003e\n\u003cli\u003eGenerate concentration data from a standard curve to support biomarker and mechanistic studies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow the ELISA works\u003c\/h3\u003e\u003cp\u003eDesigned for \u003cstrong\u003eMouse\u003c\/strong\u003e samples, this kit uses a \u003cstrong\u003eThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Mouse ADA. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Mouse ADA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Mouse ADA, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Mouse ADA in the samples is then determined by comparing the OD of the samples to the standard curve.\u003c\/strong\u003e. After binding and washing, signal is converted to concentration using a standard curve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample types\u003c\/strong\u003e: Serum, plasma, tissue homogenates and other biological fluids.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetection range\u003c\/strong\u003e: 78.13-5000 pg\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensitivity\/LoD\u003c\/strong\u003e: 19.36 pg\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAssay time\u003c\/strong\u003e: 3.5h\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELK Biotechnology","offers":[{"title":"96 T","offer_id":52966198477165,"sku":"ELK9943-96T","price":595.4,"currency_code":"USD","in_stock":true},{"title":"48 T","offer_id":52966198509933,"sku":"ELK9943-48T","price":416.0,"currency_code":"USD","in_stock":true},{"title":"96 T X 5","offer_id":52966198542701,"sku":"ELK9943-96TX5","price":2531.1,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/1h1qbq4v21p4717oo1b_a2e76d7c-8b23-4f33-9489-0053c6900a85.jpg?v=1771846645"},{"product_id":"bevacizumab-avastin-elisa-kit-bhe10809169","title":"Bevacizumab (Avastin) ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003euniversal Bevacizumab (Avastin)\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Bevacizumab is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Bevacizumab can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eBevacizumab (Avastin)\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAvastin\u003c\/strong\u003e and \u003cstrong\u003eBevacizumab\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Bevacizumab relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Bevacizumab levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eBevacizumab has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975459565933,"sku":"EU2594-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_67fe0b02-b8a0-48bf-a497-48d4fb82ab3c.jpg?v=1769599644"},{"product_id":"human-adalimumab-elisa-kit-bhe10809661","title":"Human Adalimumab ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Adalimumab\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Adalimumab is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Adalimumab can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAdalimumab\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAdalimumab\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Adalimumab relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Adalimumab levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAdalimumab has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975475097965,"sku":"EH5106-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_c00bc751-d8de-4599-9acd-aa9faf548332.jpg?v=1769599787"},{"product_id":"human-anti-adalimumab-antibody-elisa-kit-bhe10809664","title":"Human Anti-Adalimumab antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Anti-Adalimumab antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-Adalimumab antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-Adalimumab antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-Adalimumab antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAdalimumab antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-Adalimumab antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-Adalimumab antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-Adalimumab antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975475196269,"sku":"EH5107-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_b54da31e-2119-4d6f-9339-58e60c951402.jpg?v=1769599788"},{"product_id":"human-anti-bevacizumab-avastin-antibody-elisa-kit-bhe10809665","title":"Human anti-Bevacizumab (Avastin) antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman anti-Bevacizumab (Avastin) antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of anti-Bevacizumab (Avastin) antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of anti-Bevacizumab (Avastin) antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eanti-Bevacizumab (Avastin) antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eBevacizumab antibody\u003c\/strong\u003e and \u003cstrong\u003eAvastin antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how anti-Bevacizumab (Avastin) antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in anti-Bevacizumab (Avastin) antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eanti-Bevacizumab (Avastin) antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975475229037,"sku":"EH5110-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_c93bb748-8419-4091-9766-298a05affe60.jpg?v=1769599788"},{"product_id":"human-anti-adalimumab-antibody-elisa-kit-bhe10809839","title":"Human Anti-Adalimumab antibody ELISA kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Anti-Adalimumab antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-Adalimumab antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-Adalimumab antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-Adalimumab antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAnti-Adalimumab\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-Adalimumab antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-Adalimumab antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-Adalimumab antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975481225581,"sku":"EH5126-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_f330b7ac-f5d5-4d1c-8d8c-2e537a006c0a.jpg?v=1769599838"},{"product_id":"human-trastuzumab-elisa-kit-bhe10809909","title":"Human Trastuzumab ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Trastuzumab\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Trastuzumab is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Trastuzumab can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eTrastuzumab\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eTrastuzumab\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Trastuzumab relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Trastuzumab levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eTrastuzumab has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975483650413,"sku":"EH5144-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_331907be-8059-4768-aecf-9f8cc30aacc3.jpg?v=1769599856"},{"product_id":"infliximab-elisa-kit-bhe10809996","title":"Infliximab ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003euniversal Infliximab (TNF)\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Infliximab is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Infliximab can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eInfliximab (TNF)\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eTumor necrosis factor\u003c\/strong\u003e, \u003cstrong\u003eCachectin\u003c\/strong\u003e, and \u003cstrong\u003eTNF-alpha\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Infliximab relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Infliximab levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eInfliximab has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975486533997,"sku":"EU3589-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_6523dbc7-fad6-45cf-9d5f-e387dfa72736.jpg?v=1769599878"},{"product_id":"anti-infliximab-antibody-elisa-kit-bhe10809997","title":"Anti-Infliximab antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003euniversal Anti-Infliximab antibody (TNF)\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-Infliximab antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-Infliximab antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-Infliximab antibody (TNF)\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eTumor necrosis factor\u003c\/strong\u003e, \u003cstrong\u003eCachectin\u003c\/strong\u003e, and \u003cstrong\u003eTNF-alpha\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-Infliximab antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-Infliximab antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-Infliximab antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975486566765,"sku":"EU3590-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_af47b732-66d8-4512-958b-8a7add1b8697.jpg?v=1769599879"},{"product_id":"human-anti-trastuzumab-antibody-elisa-kit-bhe10812100","title":"Human Anti-trastuzumab antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Anti-trastuzumab antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-trastuzumab antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-trastuzumab antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-trastuzumab antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAnti-trastuzumab antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-trastuzumab antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-trastuzumab antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-trastuzumab antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975563506029,"sku":"EH5252-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_62ef1027-7c3e-4bc6-8a6b-ed37eac1ccac.jpg?v=1769600628"},{"product_id":"human-anti-trastuzumab-antibody-elisa-kit-bhe10812101","title":"Human Anti-trastuzumab antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Anti-trastuzumab antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-trastuzumab antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-trastuzumab antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-trastuzumab antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAnti-trastuzumab antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-trastuzumab antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-trastuzumab antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-trastuzumab antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975563538797,"sku":"EH5252-CM-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_2e38ec1f-251c-440a-b0cc-eefa7670c660.jpg?v=1769600629"},{"product_id":"human-anti-rituximab-antibody-elisa-kit-bhe10812135","title":"Human Anti-Rituximab antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Anti-Rituximab antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-Rituximab antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-Rituximab antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-Rituximab antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAnti-Rituximab\u003c\/strong\u003e and \u003cstrong\u003eRituximab antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-Rituximab antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-Rituximab antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-Rituximab antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975564685677,"sku":"EH5295-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_c7ef6db9-36eb-4f71-b824-a3038dc3c3ec.jpg?v=1769600648"},{"product_id":"human-ustekinumab-elisa-kit-bhe10812158","title":"Human Ustekinumab ELISA kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Ustekinumab (IL)\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Ustekinumab is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Ustekinumab can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eUstekinumab (IL)\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eUstekinumab\u003c\/strong\u003e and \u003cstrong\u003eAnti-Human IL-12\/IL-23, Human Antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Ustekinumab relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Ustekinumab levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eUstekinumab has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975565504877,"sku":"EH5320-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_6b621dae-de21-4066-b852-d6cebfea7923.jpg?v=1769600657"},{"product_id":"human-anti-ustekinumab-antibody-elisa-kit-bhe10812159","title":"Human Anti-Ustekinumab antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Anti-Ustekinumab antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-Ustekinumab antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-Ustekinumab antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-Ustekinumab antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eUstekinumab antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-Ustekinumab antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-Ustekinumab antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-Ustekinumab antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975565537645,"sku":"EH5321-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_5011c1f3-e03a-453a-827b-74c2edffe3ea.jpg?v=1769600658"},{"product_id":"human-anti-t-dxd-trastuzumab-deruxtecan-antibody-elisa-kit-bhe10812190","title":"Human Anti-T-DXd (trastuzumab deruxtecan) antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Anti-T-DXd (trastuzumab deruxtecan) antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-T-DXd (trastuzumab deruxtecan) antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-T-DXd (trastuzumab deruxtecan) antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-T-DXd (trastuzumab deruxtecan) antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAnti-T-DXd\u003c\/strong\u003e, \u003cstrong\u003eAnti-trastuzumab deruxtecan\u003c\/strong\u003e, and \u003cstrong\u003etrastuzumab deruxtecan antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-T-DXd (trastuzumab deruxtecan) antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-T-DXd (trastuzumab deruxtecan) antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-T-DXd (trastuzumab deruxtecan) antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975567962477,"sku":"EH5357-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_77dd0fd2-5d83-4a20-9b2a-86976ced0df6.jpg?v=1769600671"},{"product_id":"trastuzumab-emtansine-elisa-kit-bhe10812706","title":"Trastuzumab Emtansine ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003euniversal Trastuzumab Emtansine (PRO132365)\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Trastuzumab Emtansine is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Trastuzumab Emtansine can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eTrastuzumab Emtansine (PRO132365)\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eTrastuzumab Emtansine\u003c\/strong\u003e, \u003cstrong\u003eAdo-Trastuzumab emtansine\u003c\/strong\u003e, and \u003cstrong\u003ePRO132365\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Trastuzumab Emtansine relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Trastuzumab Emtansine levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eTrastuzumab Emtansine has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975593488749,"sku":"EU2672-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_e44e40ab-6873-4d0b-a397-6e1d17ad23f9.jpg?v=1769600828"},{"product_id":"bsa-elisa-kit-bhe21400006","title":"BSA ELISA KIT","description":"\u003cdiv class=\"bhp-desc\"\u003e\n\u003cstyle\u003e.bhp-desc{font-size:16px;color:#1a1a1a;line-height:1.7}.bhp-desc h2{font-size:18px;font-weight:700;color:#003366;margin:24px 0 10px;padding-bottom:6px;border-bottom:2px solid #003366}.bhp-desc p{margin:0 0 12px}.bhp-desc .bhp-spec-table{width:100%;border-collapse:collapse;margin:12px 0 18px}.bhp-desc .bhp-spec-table th{width:36%;text-align:left;padding:8px 12px;background:#e8f0fb;color:#003366;font-weight:600;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-spec-table td{padding:8px 12px;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-warning-box{background:#fff8e6;border-left:4px solid #e6a817;padding:10px 14px;margin:10px 0 14px;border-radius:0 4px 4px 0}.bhp-desc .bhp-cat-pill{display:inline-block;background:#003366;color:#fff;border-radius:20px;padding:3px 12px;font-size:13px;margin-bottom:10px}\u003c\/style\u003e\n\u003cspan class=\"bhp-cat-pill\"\u003eProcess Impurity Assay\u003c\/span\u003e\u003ch2\u003eAssay Principle\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eBSA ELISA KIT\u003c\/strong\u003e is a quantitative colorimetric ELISA designed to measure residual BSA in research samples. Concentrations are interpolated from a standard curve, giving traceable quantitative readouts for comparative analyses across experimental conditions.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable class=\"bhp-spec-table\"\u003e\n\u003ctr\u003e\n\u003cth\u003eAssay Type\u003c\/th\u003e\n\u003ctd\u003eQuantitative Colorimetric ELISA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Method\u003c\/th\u003e\n\u003ctd\u003eColorimetric\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePlate Format\u003c\/th\u003e\n\u003ctd\u003e96-well (96T)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample Types\u003c\/th\u003e\n\u003ctd\u003ePlasma, Serum\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSensitivity\u003c\/th\u003e\n\u003ctd\u003e1 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Range\u003c\/th\u003e\n\u003ctd\u003e1-32 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eRecovery\u003c\/th\u003e\n\u003ctd\u003e80-120%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStability \u0026amp; Storage\u003c\/th\u003e\n\u003ctd\u003eThe stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eShipping\u003c\/th\u003e\n\u003ctd\u003e2-8 °C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003ePerformance Data\u003c\/h2\u003e\n\u003cp\u003eThe kit provides a quantitative range of 1-32 ng\/mL, an analytical sensitivity of 1 ng\/mL, typical spike recovery of 80-120%. Plan sample dilutions so readouts fall within the linear portion of the standard curve, and evaluate matrix effects with dilution-linearity and spike-recovery controls.\u003c\/p\u003e\n\u003ch2\u003eCommon Research Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eResidual impurity testing in downstream bioprocess samples\u003c\/li\u003e\n\u003cli\u003ePurification process development and clearance monitoring\u003c\/li\u003e\n\u003cli\u003eQC method development for biologics manufacturing research\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSafety \u0026amp; Handling\u003c\/h2\u003e\n\u003cdiv class=\"bhp-warning-box\"\u003e\u003cp\u003eFor Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"AtaGenix Laboratories","offers":[{"title":"96 T","offer_id":53047343808877,"sku":"BY411018-96T","price":848.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/abinScience_Kit_Placeholder_Image_76fd5317-d232-4e8e-871d-a2a0750c17d1.jpg?v=1784823598"},{"product_id":"satralizumab-elisa-kit-bhe21400028","title":"Satralizumab ELISA Kit","description":"\u003cdiv class=\"bhp-desc\"\u003e\n\u003cstyle\u003e.bhp-desc{font-size:16px;color:#1a1a1a;line-height:1.7}.bhp-desc h2{font-size:18px;font-weight:700;color:#003366;margin:24px 0 10px;padding-bottom:6px;border-bottom:2px solid #003366}.bhp-desc p{margin:0 0 12px}.bhp-desc .bhp-spec-table{width:100%;border-collapse:collapse;margin:12px 0 18px}.bhp-desc .bhp-spec-table th{width:36%;text-align:left;padding:8px 12px;background:#e8f0fb;color:#003366;font-weight:600;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-spec-table td{padding:8px 12px;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-warning-box{background:#fff8e6;border-left:4px solid #e6a817;padding:10px 14px;margin:10px 0 14px;border-radius:0 4px 4px 0}.bhp-desc .bhp-cat-pill{display:inline-block;background:#003366;color:#fff;border-radius:20px;padding:3px 12px;font-size:13px;margin-bottom:10px}\u003c\/style\u003e\n\u003cspan class=\"bhp-cat-pill\"\u003eTherapeutic Drug Monitoring\u003c\/span\u003e\u003ch2\u003eAssay Principle\u003c\/h2\u003e\n\u003cp\u003eThis microplate immunoassay quantifies Satralizumab by colorimetric detection: samples and kit standards are processed in parallel, and absorbance values are converted to concentrations through the per-plate standard curve.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable class=\"bhp-spec-table\"\u003e\n\u003ctr\u003e\n\u003cth\u003eAssay Type\u003c\/th\u003e\n\u003ctd\u003eQuantitative Colorimetric ELISA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Method\u003c\/th\u003e\n\u003ctd\u003eColorimetric\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePlate Format\u003c\/th\u003e\n\u003ctd\u003e96-well (96T)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample Types\u003c\/th\u003e\n\u003ctd\u003ePlasma, Serum\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSensitivity\u003c\/th\u003e\n\u003ctd\u003e33.12 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Range\u003c\/th\u003e\n\u003ctd\u003e78.125 - 5,000 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eRecovery\u003c\/th\u003e\n\u003ctd\u003e80-120%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStability \u0026amp; Storage\u003c\/th\u003e\n\u003ctd\u003eThe stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eShipping\u003c\/th\u003e\n\u003ctd\u003e2-8 °C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eCAS Number\u003c\/th\u003e\n\u003ctd\u003e1535963-91-7\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eUniProt\u003c\/th\u003e\n\u003ctd\u003eP08887\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eAlternative Names\u003c\/th\u003e\n\u003ctd\u003eSapelizumab, SA-237, SA237, satralizumab-mwg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003ePerformance Data\u003c\/h2\u003e\n\u003cp\u003ePerformance is defined by a quantitative range of 78.125 - 5,000 ng\/mL, an analytical sensitivity of 33.12 ng\/mL, typical spike recovery of 80-120%. For best precision, target the central portion of the curve and confirm matrix behavior with spike-recovery and dilution-linearity checks before routine runs.\u003c\/p\u003e\n\u003ch2\u003eTarget Notes\u003c\/h2\u003e\n\u003cp\u003eThe target is also referenced in the literature as Sapelizumab, SA-237, SA237. Curated target information is available under UniProt accession P08887. The corresponding compound is registered under CAS 1535963-91-7.\u003c\/p\u003e\n\u003ch2\u003eCommon Research Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003ePharmacokinetic profiling of the drug in preclinical and translational research models\u003c\/li\u003e\n\u003cli\u003eBioanalytical method development, bridging, and comparability studies\u003c\/li\u003e\n\u003cli\u003eStability and formulation studies requiring reproducible concentration readouts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSafety \u0026amp; Handling\u003c\/h2\u003e\n\u003cdiv class=\"bhp-warning-box\"\u003e\u003cp\u003eFor Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"AtaGenix Laboratories","offers":[{"title":"96 T","offer_id":53047343972717,"sku":"DY583028-96T","price":1226.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/abinScience_Kit_Placeholder_Image_346618e1-4c7a-4381-b046-694f776e1892.jpg?v=1784823597"},{"product_id":"orforglipron-elisa-kit-bhe21400024","title":"Orforglipron ELISA Kit","description":"\u003cdiv class=\"bhp-desc\"\u003e\n\u003cstyle\u003e.bhp-desc{font-size:16px;color:#1a1a1a;line-height:1.7}.bhp-desc h2{font-size:18px;font-weight:700;color:#003366;margin:24px 0 10px;padding-bottom:6px;border-bottom:2px solid #003366}.bhp-desc p{margin:0 0 12px}.bhp-desc .bhp-spec-table{width:100%;border-collapse:collapse;margin:12px 0 18px}.bhp-desc .bhp-spec-table th{width:36%;text-align:left;padding:8px 12px;background:#e8f0fb;color:#003366;font-weight:600;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-spec-table td{padding:8px 12px;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-warning-box{background:#fff8e6;border-left:4px solid #e6a817;padding:10px 14px;margin:10px 0 14px;border-radius:0 4px 4px 0}.bhp-desc .bhp-cat-pill{display:inline-block;background:#003366;color:#fff;border-radius:20px;padding:3px 12px;font-size:13px;margin-bottom:10px}\u003c\/style\u003e\n\u003cspan class=\"bhp-cat-pill\"\u003eTherapeutic Drug Monitoring\u003c\/span\u003e\u003ch2\u003eAssay Principle\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eOrforglipron ELISA Kit\u003c\/strong\u003e is a quantitative colorimetric ELISA designed to measure Orforglipron in research samples. Concentrations are interpolated from a standard curve, giving traceable quantitative readouts for comparative analyses across experimental conditions.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable class=\"bhp-spec-table\"\u003e\n\u003ctr\u003e\n\u003cth\u003eAssay Type\u003c\/th\u003e\n\u003ctd\u003eQuantitative Colorimetric ELISA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Method\u003c\/th\u003e\n\u003ctd\u003eColorimetric\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePlate Format\u003c\/th\u003e\n\u003ctd\u003e96-well (96T)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample Types\u003c\/th\u003e\n\u003ctd\u003ePlasma, Serum\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSensitivity\u003c\/th\u003e\n\u003ctd\u003e33.12 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Range\u003c\/th\u003e\n\u003ctd\u003e78.125 - 5,000 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eRecovery\u003c\/th\u003e\n\u003ctd\u003e80-120%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStability \u0026amp; Storage\u003c\/th\u003e\n\u003ctd\u003eThe stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eShipping\u003c\/th\u003e\n\u003ctd\u003e2-8 °C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eAlternative Names\u003c\/th\u003e\n\u003ctd\u003eLY3502970, OWL 833, OWL833, OWL-833\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003ePerformance Data\u003c\/h2\u003e\n\u003cp\u003eThe kit provides a quantitative range of 78.125 - 5,000 ng\/mL, an analytical sensitivity of 33.12 ng\/mL, typical spike recovery of 80-120%. Plan sample dilutions so readouts fall within the linear portion of the standard curve, and evaluate matrix effects with dilution-linearity and spike-recovery controls.\u003c\/p\u003e\n\u003ch2\u003eTarget Notes\u003c\/h2\u003e\n\u003cp\u003eThe target is also referenced in the literature as LY3502970, OWL 833, OWL833.\u003c\/p\u003e\n\u003ch2\u003eCommon Research Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003ePharmacokinetic profiling of the drug in preclinical and translational research models\u003c\/li\u003e\n\u003cli\u003eBioanalytical method development, bridging, and comparability studies\u003c\/li\u003e\n\u003cli\u003eStability and formulation studies requiring reproducible concentration readouts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSafety \u0026amp; Handling\u003c\/h2\u003e\n\u003cdiv class=\"bhp-warning-box\"\u003e\u003cp\u003eFor Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"AtaGenix Laboratories","offers":[{"title":"96 T","offer_id":53047344038253,"sku":"DW328048-96T","price":1226.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/abinScience_Kit_Placeholder_Image_02a11ad3-6e9c-4223-af51-35e8b047aee5.jpg?v=1784823596"},{"product_id":"teriparatide-elisa-kit-bhe21400020","title":"Teriparatide ELISA Kit","description":"\u003cdiv class=\"bhp-desc\"\u003e\n\u003cstyle\u003e.bhp-desc{font-size:16px;color:#1a1a1a;line-height:1.7}.bhp-desc h2{font-size:18px;font-weight:700;color:#003366;margin:24px 0 10px;padding-bottom:6px;border-bottom:2px solid #003366}.bhp-desc p{margin:0 0 12px}.bhp-desc .bhp-spec-table{width:100%;border-collapse:collapse;margin:12px 0 18px}.bhp-desc .bhp-spec-table th{width:36%;text-align:left;padding:8px 12px;background:#e8f0fb;color:#003366;font-weight:600;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-spec-table td{padding:8px 12px;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-warning-box{background:#fff8e6;border-left:4px solid #e6a817;padding:10px 14px;margin:10px 0 14px;border-radius:0 4px 4px 0}.bhp-desc .bhp-cat-pill{display:inline-block;background:#003366;color:#fff;border-radius:20px;padding:3px 12px;font-size:13px;margin-bottom:10px}\u003c\/style\u003e\n\u003cspan class=\"bhp-cat-pill\"\u003eTherapeutic Drug Monitoring\u003c\/span\u003e\u003ch2\u003eAssay Principle\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eTeriparatide ELISA Kit\u003c\/strong\u003e provides plate-based quantitative measurement of Teriparatide. Each run carries its own standard series, so results remain comparable across plates, days, and operators in a research workflow.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable class=\"bhp-spec-table\"\u003e\n\u003ctr\u003e\n\u003cth\u003eAssay Type\u003c\/th\u003e\n\u003ctd\u003eQuantitative Colorimetric ELISA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Method\u003c\/th\u003e\n\u003ctd\u003eColorimetric\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePlate Format\u003c\/th\u003e\n\u003ctd\u003e96-well (96T)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample Types\u003c\/th\u003e\n\u003ctd\u003ePlasma, Serum\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSensitivity\u003c\/th\u003e\n\u003ctd\u003e33.12 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Range\u003c\/th\u003e\n\u003ctd\u003e78.125 - 5,000 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eRecovery\u003c\/th\u003e\n\u003ctd\u003e80-120%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStability \u0026amp; Storage\u003c\/th\u003e\n\u003ctd\u003eThe stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eShipping\u003c\/th\u003e\n\u003ctd\u003e2-8 °C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003ePerformance Data\u003c\/h2\u003e\n\u003cp\u003eThe kit provides a quantitative range of 78.125 - 5,000 ng\/mL, an analytical sensitivity of 33.12 ng\/mL, typical spike recovery of 80-120%. Plan sample dilutions so readouts fall within the linear portion of the standard curve, and evaluate matrix effects with dilution-linearity and spike-recovery controls.\u003c\/p\u003e\n\u003ch2\u003eCommon Research Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003ePharmacokinetic profiling of the drug in preclinical and translational research models\u003c\/li\u003e\n\u003cli\u003eBioanalytical method development, bridging, and comparability studies\u003c\/li\u003e\n\u003cli\u003eStability and formulation studies requiring reproducible concentration readouts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSafety \u0026amp; Handling\u003c\/h2\u003e\n\u003cdiv class=\"bhp-warning-box\"\u003e\u003cp\u003eFor Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"AtaGenix Laboratories","offers":[{"title":"96 T","offer_id":53047344103789,"sku":"DF921018-96T","price":1226.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/abinScience_Kit_Placeholder_Image_40aa4675-5f7e-4b99-8d0e-fa38aca8b2b4.jpg?v=1784823597"},{"product_id":"pegfilgrastim-elisa-kit-bhe21400021","title":"Pegfilgrastim ELISA Kit","description":"\u003cdiv class=\"bhp-desc\"\u003e\n\u003cstyle\u003e.bhp-desc{font-size:16px;color:#1a1a1a;line-height:1.7}.bhp-desc h2{font-size:18px;font-weight:700;color:#003366;margin:24px 0 10px;padding-bottom:6px;border-bottom:2px solid #003366}.bhp-desc p{margin:0 0 12px}.bhp-desc .bhp-spec-table{width:100%;border-collapse:collapse;margin:12px 0 18px}.bhp-desc .bhp-spec-table th{width:36%;text-align:left;padding:8px 12px;background:#e8f0fb;color:#003366;font-weight:600;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-spec-table td{padding:8px 12px;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-warning-box{background:#fff8e6;border-left:4px solid #e6a817;padding:10px 14px;margin:10px 0 14px;border-radius:0 4px 4px 0}.bhp-desc .bhp-cat-pill{display:inline-block;background:#003366;color:#fff;border-radius:20px;padding:3px 12px;font-size:13px;margin-bottom:10px}\u003c\/style\u003e\n\u003cspan class=\"bhp-cat-pill\"\u003eTherapeutic Drug Monitoring\u003c\/span\u003e\u003ch2\u003eAssay Principle\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003ePegfilgrastim ELISA Kit\u003c\/strong\u003e is a quantitative colorimetric ELISA designed to measure Pegfilgrastim in research samples. Concentrations are interpolated from a standard curve, giving traceable quantitative readouts for comparative analyses across experimental conditions.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable class=\"bhp-spec-table\"\u003e\n\u003ctr\u003e\n\u003cth\u003eAssay Type\u003c\/th\u003e\n\u003ctd\u003eQuantitative Colorimetric ELISA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Method\u003c\/th\u003e\n\u003ctd\u003eColorimetric\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePlate Format\u003c\/th\u003e\n\u003ctd\u003e96-well (96T)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample Types\u003c\/th\u003e\n\u003ctd\u003ePlasma, Serum\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSensitivity\u003c\/th\u003e\n\u003ctd\u003e33.12 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Range\u003c\/th\u003e\n\u003ctd\u003e78.125 - 5,000 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eRecovery\u003c\/th\u003e\n\u003ctd\u003e80-120%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStability \u0026amp; Storage\u003c\/th\u003e\n\u003ctd\u003eThe stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eShipping\u003c\/th\u003e\n\u003ctd\u003e2-8 °C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003ePerformance Data\u003c\/h2\u003e\n\u003cp\u003eThe kit provides a quantitative range of 78.125 - 5,000 ng\/mL, an analytical sensitivity of 33.12 ng\/mL, typical spike recovery of 80-120%. Plan sample dilutions so readouts fall within the linear portion of the standard curve, and evaluate matrix effects with dilution-linearity and spike-recovery controls.\u003c\/p\u003e\n\u003ch2\u003eCommon Research Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003ePharmacokinetic profiling of the drug in preclinical and translational research models\u003c\/li\u003e\n\u003cli\u003eBioanalytical method development, bridging, and comparability studies\u003c\/li\u003e\n\u003cli\u003eStability and formulation studies requiring reproducible concentration readouts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSafety \u0026amp; Handling\u003c\/h2\u003e\n\u003cdiv class=\"bhp-warning-box\"\u003e\u003cp\u003eFor Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"AtaGenix Laboratories","offers":[{"title":"96 T","offer_id":53047344136557,"sku":"DY258018-96T","price":1226.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/abinScience_Kit_Placeholder_Image_118b2c87-cb90-4ef7-984c-5c2769fc6632.jpg?v=1784823598"},{"product_id":"dulaglutide-elisa-kit-bhe21400025","title":"Dulaglutide ELISA Kit","description":"\u003cdiv class=\"bhp-desc\"\u003e\n\u003cstyle\u003e.bhp-desc{font-size:16px;color:#1a1a1a;line-height:1.7}.bhp-desc h2{font-size:18px;font-weight:700;color:#003366;margin:24px 0 10px;padding-bottom:6px;border-bottom:2px solid #003366}.bhp-desc p{margin:0 0 12px}.bhp-desc .bhp-spec-table{width:100%;border-collapse:collapse;margin:12px 0 18px}.bhp-desc .bhp-spec-table th{width:36%;text-align:left;padding:8px 12px;background:#e8f0fb;color:#003366;font-weight:600;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-spec-table td{padding:8px 12px;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-warning-box{background:#fff8e6;border-left:4px solid #e6a817;padding:10px 14px;margin:10px 0 14px;border-radius:0 4px 4px 0}.bhp-desc .bhp-cat-pill{display:inline-block;background:#003366;color:#fff;border-radius:20px;padding:3px 12px;font-size:13px;margin-bottom:10px}\u003c\/style\u003e\n\u003cspan class=\"bhp-cat-pill\"\u003eTherapeutic Drug Monitoring\u003c\/span\u003e\u003ch2\u003eAssay Principle\u003c\/h2\u003e\n\u003cp\u003eThis microplate immunoassay quantifies Dulaglutide by colorimetric detection: samples and kit standards are processed in parallel, and absorbance values are converted to concentrations through the per-plate standard curve.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable class=\"bhp-spec-table\"\u003e\n\u003ctr\u003e\n\u003cth\u003eAssay Type\u003c\/th\u003e\n\u003ctd\u003eQuantitative Colorimetric ELISA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Method\u003c\/th\u003e\n\u003ctd\u003eColorimetric\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePlate Format\u003c\/th\u003e\n\u003ctd\u003e96-well (96T)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample Types\u003c\/th\u003e\n\u003ctd\u003ePlasma, Serum\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSensitivity\u003c\/th\u003e\n\u003ctd\u003e33.12 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Range\u003c\/th\u003e\n\u003ctd\u003e78.125 - 5,000 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eRecovery\u003c\/th\u003e\n\u003ctd\u003e80-120%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStability \u0026amp; Storage\u003c\/th\u003e\n\u003ctd\u003eThe stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eShipping\u003c\/th\u003e\n\u003ctd\u003e2-8 °C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eCAS Number\u003c\/th\u003e\n\u003ctd\u003e923950-08-7\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eUniProt\u003c\/th\u003e\n\u003ctd\u003eP43220\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eAlternative Names\u003c\/th\u003e\n\u003ctd\u003eGLP-1Fc, LY2189265, TRULICITY®\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003ePerformance Data\u003c\/h2\u003e\n\u003cp\u003ePerformance is defined by a quantitative range of 78.125 - 5,000 ng\/mL, an analytical sensitivity of 33.12 ng\/mL, typical spike recovery of 80-120%. For best precision, target the central portion of the curve and confirm matrix behavior with spike-recovery and dilution-linearity checks before routine runs.\u003c\/p\u003e\n\u003ch2\u003eTarget Notes\u003c\/h2\u003e\n\u003cp\u003eThe target is also referenced in the literature as GLP-1Fc, LY2189265, TRULICITY®. Curated target information is available under UniProt accession P43220. The corresponding compound is registered under CAS 923950-08-7.\u003c\/p\u003e\n\u003ch2\u003eCommon Research Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003ePharmacokinetic profiling of the drug in preclinical and translational research models\u003c\/li\u003e\n\u003cli\u003eBioanalytical method development, bridging, and comparability studies\u003c\/li\u003e\n\u003cli\u003eStability and formulation studies requiring reproducible concentration readouts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSafety \u0026amp; Handling\u003c\/h2\u003e\n\u003cdiv class=\"bhp-warning-box\"\u003e\u003cp\u003eFor Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"AtaGenix Laboratories","offers":[{"title":"96 T","offer_id":53047344169325,"sku":"DW328038-96T","price":1226.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/DW328038-standard-1_759c23dc-a557-4483-80e1-705fff3eaf0f.webp?v=1787688158"},{"product_id":"liraglutide-elisa-kit-bhe21400026","title":"Liraglutide ELISA Kit","description":"\u003cdiv class=\"bhp-desc\"\u003e\n\u003cstyle\u003e.bhp-desc{font-size:16px;color:#1a1a1a;line-height:1.7}.bhp-desc h2{font-size:18px;font-weight:700;color:#003366;margin:24px 0 10px;padding-bottom:6px;border-bottom:2px solid #003366}.bhp-desc p{margin:0 0 12px}.bhp-desc .bhp-spec-table{width:100%;border-collapse:collapse;margin:12px 0 18px}.bhp-desc .bhp-spec-table th{width:36%;text-align:left;padding:8px 12px;background:#e8f0fb;color:#003366;font-weight:600;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-spec-table td{padding:8px 12px;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-warning-box{background:#fff8e6;border-left:4px solid #e6a817;padding:10px 14px;margin:10px 0 14px;border-radius:0 4px 4px 0}.bhp-desc .bhp-cat-pill{display:inline-block;background:#003366;color:#fff;border-radius:20px;padding:3px 12px;font-size:13px;margin-bottom:10px}\u003c\/style\u003e\n\u003cspan class=\"bhp-cat-pill\"\u003eTherapeutic Drug Monitoring\u003c\/span\u003e\u003ch2\u003eAssay Principle\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eLiraglutide ELISA Kit\u003c\/strong\u003e provides plate-based quantitative measurement of Liraglutide. Each run carries its own standard series, so results remain comparable across plates, days, and operators in a research workflow.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable class=\"bhp-spec-table\"\u003e\n\u003ctr\u003e\n\u003cth\u003eAssay Type\u003c\/th\u003e\n\u003ctd\u003eQuantitative Colorimetric ELISA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Method\u003c\/th\u003e\n\u003ctd\u003eColorimetric\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePlate Format\u003c\/th\u003e\n\u003ctd\u003e96-well (96T)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample Types\u003c\/th\u003e\n\u003ctd\u003ePlasma, Serum\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSensitivity\u003c\/th\u003e\n\u003ctd\u003e33.12 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Range\u003c\/th\u003e\n\u003ctd\u003e78.125 - 5,000 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eRecovery\u003c\/th\u003e\n\u003ctd\u003e80-120%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStability \u0026amp; Storage\u003c\/th\u003e\n\u003ctd\u003eThe stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eShipping\u003c\/th\u003e\n\u003ctd\u003e2-8 °C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003ePerformance Data\u003c\/h2\u003e\n\u003cp\u003eThe kit provides a quantitative range of 78.125 - 5,000 ng\/mL, an analytical sensitivity of 33.12 ng\/mL, typical spike recovery of 80-120%. Plan sample dilutions so readouts fall within the linear portion of the standard curve, and evaluate matrix effects with dilution-linearity and spike-recovery controls.\u003c\/p\u003e\n\u003ch2\u003eCommon Research Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003ePharmacokinetic profiling of the drug in preclinical and translational research models\u003c\/li\u003e\n\u003cli\u003eBioanalytical method development, bridging, and comparability studies\u003c\/li\u003e\n\u003cli\u003eStability and formulation studies requiring reproducible concentration readouts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSafety \u0026amp; Handling\u003c\/h2\u003e\n\u003cdiv class=\"bhp-warning-box\"\u003e\u003cp\u003eFor Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"AtaGenix Laboratories","offers":[{"title":"96 T","offer_id":53047344234861,"sku":"DW328018-96T","price":1226.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/abinScience_Kit_Placeholder_Image_c8083727-69b0-4c53-a264-ee38b43a96ce.jpg?v=1784823597"},{"product_id":"insulin-lispro-elisa-kit-bhe21400017","title":"Insulin Lispro ELISA Kit","description":"\u003cdiv class=\"bhp-desc\"\u003e\n\u003cstyle\u003e.bhp-desc{font-size:16px;color:#1a1a1a;line-height:1.7}.bhp-desc h2{font-size:18px;font-weight:700;color:#003366;margin:24px 0 10px;padding-bottom:6px;border-bottom:2px solid #003366}.bhp-desc p{margin:0 0 12px}.bhp-desc .bhp-spec-table{width:100%;border-collapse:collapse;margin:12px 0 18px}.bhp-desc .bhp-spec-table th{width:36%;text-align:left;padding:8px 12px;background:#e8f0fb;color:#003366;font-weight:600;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-spec-table td{padding:8px 12px;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-warning-box{background:#fff8e6;border-left:4px solid #e6a817;padding:10px 14px;margin:10px 0 14px;border-radius:0 4px 4px 0}.bhp-desc .bhp-cat-pill{display:inline-block;background:#003366;color:#fff;border-radius:20px;padding:3px 12px;font-size:13px;margin-bottom:10px}\u003c\/style\u003e\n\u003cspan class=\"bhp-cat-pill\"\u003eTherapeutic Drug Monitoring\u003c\/span\u003e\u003ch2\u003eAssay Principle\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eInsulin Lispro ELISA Kit\u003c\/strong\u003e provides plate-based quantitative measurement of Insulin Lispro. Each run carries its own standard series, so results remain comparable across plates, days, and operators in a research workflow.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable class=\"bhp-spec-table\"\u003e\n\u003ctr\u003e\n\u003cth\u003eAssay Type\u003c\/th\u003e\n\u003ctd\u003eQuantitative Colorimetric ELISA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Method\u003c\/th\u003e\n\u003ctd\u003eColorimetric\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePlate Format\u003c\/th\u003e\n\u003ctd\u003e96-well (96T)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample Types\u003c\/th\u003e\n\u003ctd\u003ePlasma, Serum\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSensitivity\u003c\/th\u003e\n\u003ctd\u003e33.12 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Range\u003c\/th\u003e\n\u003ctd\u003e78.125 - 5,000 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eRecovery\u003c\/th\u003e\n\u003ctd\u003e80-120%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStability \u0026amp; Storage\u003c\/th\u003e\n\u003ctd\u003eThe stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eShipping\u003c\/th\u003e\n\u003ctd\u003e2-8 °C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003ePerformance Data\u003c\/h2\u003e\n\u003cp\u003eThe kit provides a quantitative range of 78.125 - 5,000 ng\/mL, an analytical sensitivity of 33.12 ng\/mL, typical spike recovery of 80-120%. Plan sample dilutions so readouts fall within the linear portion of the standard curve, and evaluate matrix effects with dilution-linearity and spike-recovery controls.\u003c\/p\u003e\n\u003ch2\u003eCommon Research Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003ePharmacokinetic profiling of the drug in preclinical and translational research models\u003c\/li\u003e\n\u003cli\u003eBioanalytical method development, bridging, and comparability studies\u003c\/li\u003e\n\u003cli\u003eStability and formulation studies requiring reproducible concentration readouts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSafety \u0026amp; Handling\u003c\/h2\u003e\n\u003cdiv class=\"bhp-warning-box\"\u003e\u003cp\u003eFor Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"AtaGenix Laboratories","offers":[{"title":"96 T","offer_id":53047344202093,"sku":"DF990038-96T","price":1226.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/DF990038-standard-1_8663f2b3-b872-45f5-9223-33f03ee0e5ed.webp?v=1787688158"},{"product_id":"insulin-aspart-elisa-kit-bhe21400018","title":"Insulin Aspart ELISA Kit","description":"\u003cdiv class=\"bhp-desc\"\u003e\n\u003cstyle\u003e.bhp-desc{font-size:16px;color:#1a1a1a;line-height:1.7}.bhp-desc h2{font-size:18px;font-weight:700;color:#003366;margin:24px 0 10px;padding-bottom:6px;border-bottom:2px solid #003366}.bhp-desc p{margin:0 0 12px}.bhp-desc .bhp-spec-table{width:100%;border-collapse:collapse;margin:12px 0 18px}.bhp-desc .bhp-spec-table th{width:36%;text-align:left;padding:8px 12px;background:#e8f0fb;color:#003366;font-weight:600;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-spec-table td{padding:8px 12px;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-warning-box{background:#fff8e6;border-left:4px solid #e6a817;padding:10px 14px;margin:10px 0 14px;border-radius:0 4px 4px 0}.bhp-desc .bhp-cat-pill{display:inline-block;background:#003366;color:#fff;border-radius:20px;padding:3px 12px;font-size:13px;margin-bottom:10px}\u003c\/style\u003e\n\u003cspan class=\"bhp-cat-pill\"\u003eTherapeutic Drug Monitoring\u003c\/span\u003e\u003ch2\u003eAssay Principle\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eInsulin Aspart ELISA Kit\u003c\/strong\u003e is a quantitative colorimetric ELISA designed to measure Insulin Aspart in research samples. Concentrations are interpolated from a standard curve, giving traceable quantitative readouts for comparative analyses across experimental conditions.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable class=\"bhp-spec-table\"\u003e\n\u003ctr\u003e\n\u003cth\u003eAssay Type\u003c\/th\u003e\n\u003ctd\u003eQuantitative Colorimetric ELISA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Method\u003c\/th\u003e\n\u003ctd\u003eColorimetric\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePlate Format\u003c\/th\u003e\n\u003ctd\u003e96-well (96T)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample Types\u003c\/th\u003e\n\u003ctd\u003ePlasma, Serum\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSensitivity\u003c\/th\u003e\n\u003ctd\u003e33.12 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Range\u003c\/th\u003e\n\u003ctd\u003e78.125 - 5,000 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eRecovery\u003c\/th\u003e\n\u003ctd\u003e80-120%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStability \u0026amp; Storage\u003c\/th\u003e\n\u003ctd\u003eThe stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eShipping\u003c\/th\u003e\n\u003ctd\u003e2-8 °C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003ePerformance Data\u003c\/h2\u003e\n\u003cp\u003eThe kit provides a quantitative range of 78.125 - 5,000 ng\/mL, an analytical sensitivity of 33.12 ng\/mL, typical spike recovery of 80-120%. Plan sample dilutions so readouts fall within the linear portion of the standard curve, and evaluate matrix effects with dilution-linearity and spike-recovery controls.\u003c\/p\u003e\n\u003ch2\u003eCommon Research Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003ePharmacokinetic profiling of the drug in preclinical and translational research models\u003c\/li\u003e\n\u003cli\u003eBioanalytical method development, bridging, and comparability studies\u003c\/li\u003e\n\u003cli\u003eStability and formulation studies requiring reproducible concentration readouts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSafety \u0026amp; Handling\u003c\/h2\u003e\n\u003cdiv class=\"bhp-warning-box\"\u003e\u003cp\u003eFor Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"AtaGenix Laboratories","offers":[{"title":"96 T","offer_id":53047344529773,"sku":"DF990028-96T","price":1226.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/abinScience_Kit_Placeholder_Image_611ed1be-3d5e-4f31-b01b-651920aed33b.jpg?v=1784823598"},{"product_id":"retatrutide-elisa-kit-bhe21400023","title":"Retatrutide ELISA Kit","description":"\u003cdiv class=\"bhp-desc\"\u003e\n\u003cstyle\u003e.bhp-desc{font-size:16px;color:#1a1a1a;line-height:1.7}.bhp-desc h2{font-size:18px;font-weight:700;color:#003366;margin:24px 0 10px;padding-bottom:6px;border-bottom:2px solid #003366}.bhp-desc p{margin:0 0 12px}.bhp-desc .bhp-spec-table{width:100%;border-collapse:collapse;margin:12px 0 18px}.bhp-desc .bhp-spec-table th{width:36%;text-align:left;padding:8px 12px;background:#e8f0fb;color:#003366;font-weight:600;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-spec-table td{padding:8px 12px;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-warning-box{background:#fff8e6;border-left:4px solid #e6a817;padding:10px 14px;margin:10px 0 14px;border-radius:0 4px 4px 0}.bhp-desc .bhp-cat-pill{display:inline-block;background:#003366;color:#fff;border-radius:20px;padding:3px 12px;font-size:13px;margin-bottom:10px}\u003c\/style\u003e\n\u003cspan class=\"bhp-cat-pill\"\u003eTherapeutic Drug Monitoring\u003c\/span\u003e\u003ch2\u003eAssay Principle\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eRetatrutide ELISA Kit\u003c\/strong\u003e provides plate-based quantitative measurement of Retatrutide. Each run carries its own standard series, so results remain comparable across plates, days, and operators in a research workflow.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable class=\"bhp-spec-table\"\u003e\n\u003ctr\u003e\n\u003cth\u003eAssay Type\u003c\/th\u003e\n\u003ctd\u003eQuantitative Colorimetric ELISA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Method\u003c\/th\u003e\n\u003ctd\u003eColorimetric\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePlate Format\u003c\/th\u003e\n\u003ctd\u003e96-well (96T)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample Types\u003c\/th\u003e\n\u003ctd\u003ePlasma, Serum\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSensitivity\u003c\/th\u003e\n\u003ctd\u003e33.12 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Range\u003c\/th\u003e\n\u003ctd\u003e78.125 - 5,000 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eRecovery\u003c\/th\u003e\n\u003ctd\u003e80-120%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStability \u0026amp; Storage\u003c\/th\u003e\n\u003ctd\u003eThe stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eShipping\u003c\/th\u003e\n\u003ctd\u003e2-8 °C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eAlternative Names\u003c\/th\u003e\n\u003ctd\u003eLY3437943\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003ePerformance Data\u003c\/h2\u003e\n\u003cp\u003eThe kit provides a quantitative range of 78.125 - 5,000 ng\/mL, an analytical sensitivity of 33.12 ng\/mL, typical spike recovery of 80-120%. Plan sample dilutions so readouts fall within the linear portion of the standard curve, and evaluate matrix effects with dilution-linearity and spike-recovery controls.\u003c\/p\u003e\n\u003ch2\u003eTarget Notes\u003c\/h2\u003e\n\u003cp\u003eThe target is also referenced in the literature as LY3437943.\u003c\/p\u003e\n\u003ch2\u003eCommon Research Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003ePharmacokinetic profiling of the drug in preclinical and translational research models\u003c\/li\u003e\n\u003cli\u003eBioanalytical method development, bridging, and comparability studies\u003c\/li\u003e\n\u003cli\u003eStability and formulation studies requiring reproducible concentration readouts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSafety \u0026amp; Handling\u003c\/h2\u003e\n\u003cdiv class=\"bhp-warning-box\"\u003e\u003cp\u003eFor Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"AtaGenix Laboratories","offers":[{"title":"96 T","offer_id":53047344562541,"sku":"DW328058-96T","price":1226.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/DW328058-standard-1_ceeb6bb9-3765-4071-ba35-12fed554ab3c.webp?v=1787688158"},{"product_id":"protein-a-elisa-kit-bhe21400005","title":"Protein A ELISA KIT","description":"\u003cdiv class=\"bhp-desc\"\u003e\n\u003cstyle\u003e.bhp-desc{font-size:16px;color:#1a1a1a;line-height:1.7}.bhp-desc h2{font-size:18px;font-weight:700;color:#003366;margin:24px 0 10px;padding-bottom:6px;border-bottom:2px solid #003366}.bhp-desc p{margin:0 0 12px}.bhp-desc .bhp-spec-table{width:100%;border-collapse:collapse;margin:12px 0 18px}.bhp-desc .bhp-spec-table th{width:36%;text-align:left;padding:8px 12px;background:#e8f0fb;color:#003366;font-weight:600;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-spec-table td{padding:8px 12px;vertical-align:top;border:1px solid #ccd9f0}.bhp-desc .bhp-warning-box{background:#fff8e6;border-left:4px solid #e6a817;padding:10px 14px;margin:10px 0 14px;border-radius:0 4px 4px 0}.bhp-desc .bhp-cat-pill{display:inline-block;background:#003366;color:#fff;border-radius:20px;padding:3px 12px;font-size:13px;margin-bottom:10px}\u003c\/style\u003e\n\u003cspan class=\"bhp-cat-pill\"\u003eProcess Impurity Assay\u003c\/span\u003e\u003ch2\u003eAssay Principle\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eProtein A ELISA KIT\u003c\/strong\u003e provides plate-based quantitative measurement of residual Protein A. Each run carries its own standard series, so results remain comparable across plates, days, and operators in a research workflow.\u003c\/p\u003e\n\u003ch2\u003eBackground\u003c\/h2\u003e\n\u003cp\u003eProtein A ELISA kit applies the quantitative sandwich enzyme immunoassay technique. The microtiter plate has been pre-coated with a monoclonal antibody specific for Protein A. Samples containing Protein A are first diluted in the Sample Diluent provided with the kits. The Denaturing Buffer is then added and mixed to dissociate the Protein A from the product antibody. The samples are then reacted in microtiter strips coated with a monoclonal anti-Protein A capture antibody. A second anti-Protein A biotinylated monoclonal antibody is simultaneously reacted forming a sandwich complex of solid phase antibody-Protein A: biotin labeled antibody. After a wash step to remove any unbound reactants, Streptavidin labeled HRP is added to each well. After a short incubation period, the strips are then reacted with TMB substrate. The enzyme-substrate reaction is terminated by addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm. A standard curve is plotted relating the intensity of the color (OD) to the concentration of standards. The Protein A concentration in each sample is interpolated from this standard curve.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable class=\"bhp-spec-table\"\u003e\n\u003ctr\u003e\n\u003cth\u003eAssay Type\u003c\/th\u003e\n\u003ctd\u003eQuantitative Colorimetric ELISA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Method\u003c\/th\u003e\n\u003ctd\u003eColorimetric\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePlate Format\u003c\/th\u003e\n\u003ctd\u003e96-well (96T)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSample Types\u003c\/th\u003e\n\u003ctd\u003ePlasma, Serum\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSensitivity\u003c\/th\u003e\n\u003ctd\u003e20 pg\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eDetection Range\u003c\/th\u003e\n\u003ctd\u003e0.078-5 ng\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eRecovery\u003c\/th\u003e\n\u003ctd\u003e80-120%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStability \u0026amp; Storage\u003c\/th\u003e\n\u003ctd\u003eThe stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eShipping\u003c\/th\u003e\n\u003ctd\u003e2-8 °C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003ePerformance Data\u003c\/h2\u003e\n\u003cp\u003eThe kit provides a quantitative range of 0.078-5 ng\/mL, an analytical sensitivity of 20 pg\/mL, typical spike recovery of 80-120%. Plan sample dilutions so readouts fall within the linear portion of the standard curve, and evaluate matrix effects with dilution-linearity and spike-recovery controls.\u003c\/p\u003e\n\u003ch2\u003eCommon Research Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eResidual impurity testing in downstream bioprocess samples\u003c\/li\u003e\n\u003cli\u003ePurification process development and clearance monitoring\u003c\/li\u003e\n\u003cli\u003eQC method development for biologics manufacturing research\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSafety \u0026amp; Handling\u003c\/h2\u003e\n\u003cdiv class=\"bhp-warning-box\"\u003e\u003cp\u003eFor Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"AtaGenix Laboratories","offers":[{"title":"96 T","offer_id":53047344726381,"sku":"JN856018-96T","price":848.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/abinScience_Kit_Placeholder_Image_ce12f063-af55-45d1-9c65-4309ab70575f.jpg?v=1784823596"}],"url":"https:\/\/www.ebiohippo.com\/collections\/rt-drug-development-elisa-kits.oembed?page=4","provider":"BioHippo","version":"1.0","type":"link"}